HIMS

Hims & Hers Health Inc

Sep 18 • 12:14PM ET

54.83

+4.49 8.91 %

Consumer Defensive • Household & Personal Products • USA • NYSE

Peers: ELF LFMD PRGO TDOC GDRX AMWL DOCS CLOV RXRX TWST

| Held by: IJH IWM VTI VB ULTY VBK VXF IWO XMHQ MDY

Index	RUT	P/E	68.63	EPS (ttm)	0.80	Insider Own	10.34%	Shs Outstand	217.38M	Perf Week	5.94%
Market Cap	12.39B	Forward P/E	69.44	EPS next Y	0.79	Insider Trans	-10.41%	Shs Float	202.66M	Perf Month	30.00%
Enterprise Value	12.29B	PEG	2.69	EPS next Q	0.10	Inst Own	77.75%	Short Float	36.83%	Perf Quarter	-10.21%
Income	193.60M	P/S	6.16	EPS this Y	7.72%	Inst Trans	10.95%	Short Ratio	2.08	Perf Half Y	61.85%
Sales	2.01B	P/B	22.00	EPS next Y	38.32%	ROA	16.42%	Short Interest	74.64M	Perf YTD	126.78%
Book/sh	2.49	P/C	10.83	EPS next 5Y	25.47%	ROE	41.88%	52W High	72.98 -24.86%	Perf Year	236.82%
Cash/sh	5.06	P/FCF	106.41	EPS past 3/5Y	- 17.22%	ROIC	12.07%	52W Low	15.73 248.60%	Perf 3Y	807.86%
Dividend Est.	-	EV/EBITDA	74.04	Sales past 3/5Y	75.77% -	Gross Margin	67.11%	Volatility	7.89% 6.32%	Perf 5Y	399.86%
Dividend TTM	-	EV/Sales	6.11	EPS Y/Y TTM	947.74%	Oper. Margin	6.80%	ATR (14)	3.44	Perf 10Y	-
Dividend Ex-Date	-	Quick Ratio	4.46	Sales Y/Y TTM	88.69%	Profit Margin	9.62%	RSI (14)	59.95	Recom	2.82
Dividend Gr. 3/5Y	- -	Current Ratio	4.98	EPS Q/Q	198.06%	SMA20	15.16%	Beta	2.22	Target Price	50.66
Payout	0.00%	Debt/Eq	1.86	Sales Q/Q	72.61%	SMA50	8.28%	Rel Volume	0.97	Prev Close	50.35
Employees	1637	LT Debt/Eq	1.85	Earnings	Aug 04 AMC	SMA200	28.91%	Avg Volume	35.82M	Price	54.83
IPO	Sep 13, 2019	Option/Short	Yes / Yes	EPS/Sales Surpr.	12.73% -1.24%	Trades		Volume	15,610,669	Change	8.91%

Date	Action	Analyst	Rating Change	Price Target Change
Jun-23-25	Downgrade	Needham	Buy → Hold
Jun-04-25	Reiterated	Needham	Buy	$61 → $65
Apr-29-25	Downgrade	TD Cowen	Buy → Hold	$30
Feb-18-25	Downgrade	Morgan Stanley	Overweight → Equal-Weight	$42 → $60
Jan-10-25	Downgrade	Citigroup	Neutral → Sell	$24 → $25
Jan-07-25	Initiated	BTIG Research	Buy	$35
Dec-17-24	Initiated	Morgan Stanley	Overweight	$42
Nov-14-24	Downgrade	BofA Securities	Buy → Underperform
Aug-22-24	Initiated	Needham	Buy	$24
Aug-09-24	Downgrade	Imperial Capital	Outperform → In-line
May-22-24	Downgrade	Citigroup	Buy → Neutral	$16 → $20
Apr-16-24	Downgrade	Jefferies	Buy → Hold	$17 → $15
Apr-10-24	Initiated	Canaccord Genuity	Buy	$20
Feb-28-24	Upgrade	Imperial Capital	In-line → Outperform	$16
Feb-26-24	Initiated	Leerink Partners	Market Perform	$10
Dec-07-23	Initiated	Imperial Capital	In-line	$9
Jul-28-23	Initiated	TD Cowen	Outperform	$11
Apr-11-23	Initiated	Robert W. Baird	Neutral	$10
Feb-09-23	Upgrade	Jefferies	Hold → Buy	$7 → $11
Nov-08-22	Upgrade	SVB Leerink	Mkt Perform → Outperform	$5

Show Previous Ratings

Today 11:51AM	Hims & Hers, Eli Lilly, Novo Nordisk Face FDA Scrutiny: What It Means For Weight-Loss ETFs (Benzinga) +8.91%
Sep-17-25 02:03PM	Weight-loss drug giants face sternest test yet (TheStreet)
Sep-16-25 04:14PM	FDA Slams Hims & Hers With A Warning Letter. Investors Slam Hims Stock. (Investor's Business Daily) -5.69%
04:11PM	Stocks to Watch Recap: Hershey, Oracle, New York Times (The Wall Street Journal)
02:51PM	Hims & Hers Health (HIMS) Stock Trades Down, Here Is Why (StockStory)
02:11PM	Loading…
02:11PM	Gold's record high, Rocket Lab equity offering, FDA warns Hims (Yahoo Finance Video)
02:01PM	Leverage Shares Launches First 3x Single-Stock ETPs on HOOD, HIMS, UNH and Others (etf.com)
12:59PM	Hims & Hers Health, Inc. (HIMS): A Bull Case Theory (Insider Monkey)
11:28AM	Huge News for Hims & Hers Stock (Motley Fool)
10:23AM	Hims & Hers Expands AI and Technology Focus to Advance Digital Care (Zacks)
09:23AM	Company News for Sep 16, 2025 (Zacks)
12:03AM	Hims & Hers Health (HIMS): Buy, Sell, or Hold Post Q2 Earnings? (StockStory)
Sep-15-25 05:45PM	Hims & Hers Health, Inc. (HIMS) Stock Sinks As Market Gains: Here's Why (Zacks)
12:26PM	Hims & Hers Is in the FDA's Crosshairs. It's a Risk to the Stock. (Barrons.com)
11:41AM	Hims & Hers Stock Falls After FDA Warns on Super Bowl Campaign (GuruFocus.com)
11:40AM	Loading…
11:40AM	OMCL or HIMS: Which Is the Better Value Stock Right Now? (Zacks)
09:34AM	Musk buys Tesla, China vs. US chips, Hims: Trending Tickers (Yahoo Finance Video)
09:00AM	Investors Heavily Search Hims & Hers Health, Inc. (HIMS): Here is What You Need to Know (Zacks)
07:25AM	Hims & Hers shares drop after FDA chief flags ad violations (Investing.com)
Sep-12-25 04:01PM	Hims & Hers Health (HIMS) Stock Trades Up, Here Is Why (StockStory) +7.23%
10:02AM	Hims & Hers Surges 64.1% in 6 Months: How to Play the Stock? (Zacks)
Sep-11-25 11:56AM	Hims & Hers Health (HIMS) Stock Trades Up, Here Is Why (StockStory) +8.33%
Sep-10-25 01:30PM	Why Hims & Hers Health (HIMS) Stock Is Trading Up Today (StockStory)
11:25AM	Hims & Hers Stock Jumps On Long-Awaited Foray Into Testosterone (Investor's Business Daily)
11:05AM	Trump tasks FDA to crack down on misleading drug advertising (Pharmaceutical Technology)
09:00AM	Hims Launches New Category in Men's Health with Exclusive Branded Oral Testosterone and Expanded Personalized Treatments (Business Wire)
08:50AM	Hims & Hers Health Expands Testosterone Offerings (The Wall Street Journal)
Sep-09-25 07:12PM	Trump aims to curb direct-to-consumer ads for drugs. Hims & Hers Health could be targeted. (MarketWatch)
05:45PM	Hims & Hers Health, Inc. (HIMS) Stock Drops Despite Market Gains: Important Facts to Note (Zacks)
Sep-08-25 11:10AM	Hims & Hers Expanding Partnerships to Build a Global Health Ecosystem (Zacks)
02:33PM	Loading…
Sep-04-25 02:33PM	Hims & Hers 'Personalized' Health Products Drove A 1,600% Share Price Increase In Less Than 4 Years (Investor's Business Daily) +8.21%
12:33PM	Hims & Hers (HIMS) Steals Spotlight as Court Junks Eli Lilly Lawsuit vs 4 Telehealth Firms (Insider Monkey)
12:16PM	Why Hims & Hers Health (HIMS) Stock Is Up Today (StockStory)
06:24AM	4 Top Stocks to Buy in September (Motley Fool)
Sep-03-25 02:12PM	Lyft convertible notes, Hims & Hers surges, Constellation Brands (Yahoo Finance Video) +7.06%
01:19PM	Hims & Hers gains after court rejects Eli Lillys case against Willow (Investing.com)
Sep-02-25 04:25PM	Here is What to Know Beyond Why Hims & Hers Health, Inc. (HIMS) is a Trending Stock (Zacks)
01:11PM	HIMS' Personalized Wellness Platform Expands Preventive Care Access (Zacks)
Aug-28-25 10:08AM	HIMS vs. AMWL: Which Stock Has the Stronger Global Growth Strategy? (Zacks)
Aug-27-25 03:00PM	Why Cracker Barrel is on its way to meme stock status (Yahoo Finance Video)
10:44AM	Hims & Hers Scales Growth Through Subscriptions and Care Expansion (Zacks)
Aug-25-25 10:30AM	BC-Most Active Stocks (Associated Press Finance)
Aug-22-25 09:00AM	Is Trending Stock Hims & Hers Health, Inc. (HIMS) a Buy Now? (Zacks)
Aug-21-25 11:31PM	Healthcare Technology Stocks Q2 Highlights: Hims & Hers Health (NYSE:HIMS) (StockStory)
02:53PM	Got $5,000? 3 Tech Stocks to Buy and Hold for the Long Term (Motley Fool)
09:05AM	Ozempic Boom: Hims & Eli Lilly Lead Healthcare Bets (MarketBeat)
Aug-20-25 12:33AM	Truist Cuts Hims & Hers Health, Inc. (HIMS) Price Target, Cites Mixed Revenue Outlook (Insider Monkey)
Aug-19-25 04:50PM	Why Hims & Hers Health (HIMS) Stock Is Falling Today (StockStory) -6.47%
04:43PM	Shareholders of Hims & Hers Health, Inc. (HIMS): Protect Your Rights Before August 25, 2025 - Contact Levi & Korsinsky (Newsfile)
10:01AM	Hims & Hers Fuels Growth via Market Expansion and New Care Verticals (Zacks)
Aug-18-25 07:04PM	Insiders Trade Millions in NVIDIA-Linked Navitas, Hims, & Shift4 (MarketBeat)
01:00PM	Why is GDRX stock up 30% today? GoodRx strikes deal to sell Ozempic and Wegovy after Novo Nordisks breakup with Hims (FastCompany)
12:34PM	Wegovy News Pushes Novo Nordisk Stock Higher (Barrons.com)
12:18PM	Meta's reported shake-up, Hims & Hers sinks on GoodRxNovo deal (Yahoo Finance Video)
10:30AM	BC-Most Active Stocks (Associated Press Finance)
09:00AM	GoodRx stock soars after striking deal to sell Novo Nordisk's GLP-1s for $499/month (Yahoo Finance)
09:00AM	GoodRx begins selling Novo Nordisk GLP-1s for cash price (Yahoo Finance)
09:00AM	Novo Nordisk Stock Is Jumping. The Good News Pushing Shares Higher. (Barrons.com)
07:27AM	Stock Market Today: All's quiet on the Wyoming front (TheStreet)
03:58AM	Despite FDA ruling, compounded GLP-1s are still giving Novo and Lilly headaches on the market (Pharma Voice)
Aug-15-25 04:45PM	Draft of Trumps Health Blueprint Avoids Industry Crackdown (Bloomberg)
08:48AM	Big Pharma Has a New Vision for Selling Drugs. It's Going to the Mattresses. (Barrons.com)
08:43AM	HIMS: Hims & Hers Shares Sink After FTC Probe Details Emerge (GuruFocus.com)
Aug-14-25 04:48PM	Hims & Hers stock drops after FTC probe report (Investing.com)
03:24PM	HIMS CEO Family Trust Sells $33M Shares Following Novo Nordisk Accusations - Hagens Berman (Newsfile)
08:35AM	Zacks Investment Ideas feature highlights: IonQ, Hims and Hers, Eli Lilly and TransMedics (Zacks)
Aug-13-25 02:16PM	3 Unusual Insider Transactions you Should Know About (Zacks)
12:51PM	Hims & Hers (HIMS) Falls as Key Executives Dispose Shares (Insider Monkey)
12:43PM	Hims & Hers Stock Plunges 21.3% in 3 Months: Time to Hold or Exit? (Zacks)
10:30AM	BC-Most Active Stocks (Associated Press Finance)
12:36AM	1 Mid-Cap Stock with Competitive Advantages and 2 We Avoid (StockStory)
12:13AM	The Top 5 Analyst Questions From Hims & Hers Health's Q2 Earnings Call (StockStory)
12:05AM	HIMS Q2 Deep Dive: International Expansion and Product Shifts Define Next Growth Phase (StockStory)
Aug-12-25 03:45PM	Why Hims & Hers Health (HIMS) Shares Are Trading Lower Today (StockStory)
03:21PM	Hims & Hers CEO sells $33 million in stock after a massive rally (MarketWatch)
12:12PM	Hims & Hers Drives the Consumer-Centric Transformation in Digital Care (Zacks)
Aug-11-25 10:30AM	BC-Most Active Stocks (Associated Press Finance)
10:00AM	Where Will Hims & Hers Be in 5 Years? (Motley Fool)
09:05AM	Novo ramps up lawsuits over Wegovy copies - but not for Hims & Hers (Reuters Videos)
09:00AM	Is Most-Watched Stock Hims & Hers Health, Inc. (HIMS) Worth Betting on Now? (Zacks)
06:09AM	As Novo Nordisk ramps up lawsuits over Wegovy copies, investors ask where is Hims? (Reuters)
Aug-10-25 04:35AM	Hims & Hers Shares Plunge. Is This a Buying Opportunity or Should Investors Run for the Hills? (Motley Fool)
Aug-09-25 07:00AM	MarketBeat Week in Review - 08/04 - 08/08 (MarketBeat)
06:32AM	Why Hims & Hers Stock Sank This Week (Motley Fool)
Aug-08-25 04:22PM	Capital Compounders for Investors (Motley Fool)
12:48PM	Hims Stock Gets Booted Off IBD 50 While Other Volatile Names Hang On (Investor's Business Daily)
11:00AM	MarketsandMarkets' 360Quadrants Recognizes Top Startups and SMEs in the Hospital Information System Quadrant Report 2025 (PR Newswire)
Aug-07-25 07:00PM	Hims & Hers: A Game-Changer in Telehealth or Just Another Fad? (Motley Fool)
05:27PM	Did You Lose Money on Hims & Hers Health, Inc. (HIMS)? Levi & Korsinsky Urges Investors to Act Before August 25, 2025 (Newsfile)
10:51AM	Hims & Hers Redefines Virtual Care With Integrated Tech Platforms (Zacks)
10:30AM	BC-Most Active Stocks (Associated Press Finance)
12:46AM	2 Surging Stocks to Research Further and 1 We Turn Down (StockStory)
Aug-06-25 04:52PM	Novo Nordisk Slumps As 'Unlawful' Knockoffs Pressure Wegovy, Ozempic (Investor's Business Daily) -7.91%
02:04PM	Cash pay is 'going to constitute a major part of the Wegovy business': Novo Nordisk CFO (Yahoo Finance)
12:24PM	Hims & Hers (HIMS) Falls 12.36% on Weaker Revenues (Insider Monkey)
09:16AM	Novo Nordisk Slumps As It Cautions 'Unsafe And Unlawful' Knockoffs Will Pressure Wegovy (Investor's Business Daily)
08:42AM	Diagnosis: Hims & Hers' August Price Dip Is an Opportunity to Buy (MarketBeat)
07:05AM	These Are the Smartest Growth Stocks to Invest $1,000 in Today (Motley Fool)
05:54AM	AI and GLP-1s were the hot post-pandemic trades, but only one is thriving (Yahoo Finance)
Aug-05-25 05:15PM	Stocks to Watch Recap: Palantir, Coinbase, Gartner, Pfizer (The Wall Street Journal) -12.36%

Hims & Hers Health, Inc. operates a telehealth consultation platform. It connects consumers to healthcare professionals, enabling them to access medical care for mental health, sexual health, dermatology and primary care. The company was founded in 2017 and is headquartered in San Francisco, CA.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
Chi Michael	Chief Commercial Officer	Sep 15 '25	Option Exercise	6.19	4,150	25,680	282,804	Sep 17 07:24 PM
Chi Michael	Chief Commercial Officer	Sep 15 '25	Sale	56.00	4,150	232,400	278,654	Sep 17 07:24 PM
Dudum Andrew	Chief Executive Officer	Sep 16 '25	Option Exercise	2.43	125,335	304,564	268,759	Sep 17 07:24 PM
Dudum Andrew	Chief Executive Officer	Sep 16 '25	Sale	53.48	128,127	6,852,300	160,425	Sep 17 07:24 PM
Dudum Andrew	Chief Executive Officer	Sep 16 '25	Sale	53.27	47,534	2,532,325	95,058	Sep 17 07:24 PM
Okupe Oluyemi	Chief Financial Officer	Sep 15 '25	Option Exercise	5.01	110,000	551,100	273,984	Sep 17 07:24 PM
Okupe Oluyemi	Chief Financial Officer	Sep 15 '25	Sale	55.35	145,000	8,026,076	128,984	Sep 17 07:24 PM
Dudum Andrew	Officer	Sep 17 '25	Proposed Sale	50.57	65,110	3,292,904		Sep 17 12:44 PM
Boughton Soleil	Officer	Sep 17 '25	Proposed Sale	50.50	2,637	133,168		Sep 17 11:15 AM
Carroll Patrick Harrison	Officer	Sep 17 '25	Proposed Sale	50.50	10,021	506,060		Sep 17 10:20 AM
Chi Michael	Officer	Sep 17 '25	Proposed Sale	50.50	13,749	694,324		Sep 17 10:07 AM
Becklund Irene	Officer	Sep 17 '25	Proposed Sale	50.50	8,410	424,705		Sep 17 09:50 AM
Dudum Andrew	Officer	Sep 16 '25	Proposed Sale	53.42	175,661	9,384,626		Sep 16 11:29 AM
Oluyemi Okupe	Officer	Sep 15 '25	Proposed Sale	53.96	145,000	7,824,200		Sep 15 06:35 PM
Chi Michael	Officer	Sep 15 '25	Proposed Sale	56.00	4,150	232,400		Sep 15 11:49 AM
Okupe Oluyemi	Chief Financial Officer	Aug 26 '25	Option Exercise	5.01	11,581	58,021	128,387	Aug 28 04:34 PM
Okupe Oluyemi	Chief Financial Officer	Aug 26 '25	Sale	43.69	11,581	505,968	116,806	Aug 28 04:34 PM
Boughton Soleil	Chief Legal Officer	Aug 25 '25	Sale	44.53	2,571	114,487	150,450	Aug 26 04:35 PM
Boughton Soleil	Officer	Aug 25 '25	Proposed Sale	44.53	2,571	114,487		Aug 25 09:46 AM
Dudum Andrew	Chief Executive Officer	Aug 18 '25	Option Exercise	2.43	125,335	304,564	197,855	Aug 20 04:14 PM
Dudum Andrew	Chief Executive Officer	Aug 18 '25	Sale	45.06	128,127	5,773,242	89,521	Aug 20 04:14 PM
Dudum Andrew	Chief Executive Officer	Aug 18 '25	Sale	45.05	47,534	2,141,492	142,592	Aug 20 04:14 PM
Dudum Andrew	Officer	Aug 18 '25	Proposed Sale	45.05	47,534	2,141,494		Aug 18 12:33 PM
Dudum Andrew	Officer	Aug 18 '25	Proposed Sale	45.22	128,127	5,793,903		Aug 18 10:22 AM
Okupe Oluyemi	Chief Financial Officer	Aug 13 '25	Option Exercise	5.01	11,581	58,021	65,665	Aug 15 04:18 PM
Okupe Oluyemi	Chief Financial Officer	Aug 13 '25	Sale	48.05	11,581	556,420	116,806	Aug 15 04:18 PM
Melissa Baird	Officer	Aug 12 '25	Proposed Sale	47.96	33,333	1,598,651		Aug 12 05:22 PM
Boughton Soleil	Chief Legal Officer	Aug 11 '25	Sale	51.64	2,572	132,818	153,021	Aug 12 04:33 PM
Dudum Andrew	Chief Executive Officer	Aug 07 '25	Sale	50.58	660,000	33,384,120	2,214,769	Aug 11 05:07 PM
Boughton Soleil	Officer	Aug 11 '25	Proposed Sale	51.64	2,572	132,818		Aug 11 10:18 AM
Carroll Patrick Harrison	Chief Medical Officer	Aug 06 '25	Sale	53.58	60,000	3,214,878	169,940	Aug 08 04:19 PM
Carroll Patrick Harrison	Officer	Aug 06 '25	Proposed Sale	53.58	60,000	3,214,881		Aug 06 01:27 PM
Chi Michael	Chief Commercial Officer	Jul 31 '25	Option Exercise	7.09	26,350	186,830	305,004	Aug 04 04:21 PM
Chi Michael	Chief Commercial Officer	Aug 01 '25	Option Exercise	11.53	250	2,882	278,904	Aug 04 04:21 PM
Chi Michael	Chief Commercial Officer	Jul 31 '25	Sale	67.00	26,350	1,765,450	278,654	Aug 04 04:21 PM
Chi Michael	Chief Commercial Officer	Aug 01 '25	Sale	64.44	250	16,110	278,654	Aug 04 04:21 PM
Chi Michael	Officer	Aug 01 '25	Proposed Sale	64.44	250	16,110		Aug 01 11:12 AM
Chi Michael	Officer	Jul 31 '25	Proposed Sale	67.00	26,350	1,765,450		Jul 31 11:02 AM
Boughton Soleil	Chief Legal Officer	Jul 28 '25	Sale	58.70	2,572	150,976	155,593	Jul 29 04:25 PM
Boughton Soleil	Officer	Jul 28 '25	Proposed Sale	58.70	2,572	150,976		Jul 28 12:59 PM
Chi Michael	Chief Commercial Officer	Jul 23 '25	Option Exercise	5.25	13,750	72,146	292,404	Jul 25 05:20 PM
Chi Michael	Chief Commercial Officer	Jul 24 '25	Option Exercise	5.01	2,100	10,521	280,754	Jul 25 05:20 PM
Chi Michael	Chief Commercial Officer	Jul 23 '25	Sale	56.00	13,750	770,000	278,654	Jul 25 05:20 PM
Chi Michael	Chief Commercial Officer	Jul 24 '25	Sale	57.52	2,100	120,792	278,654	Jul 25 05:20 PM
Chi Michael	Officer	Jul 24 '25	Proposed Sale	57.52	2,100	120,792		Jul 24 10:44 AM
Dudum Andrew	Chief Executive Officer	Jul 21 '25	Option Exercise	2.43	125,335	304,564	142,313	Jul 23 04:12 PM
Dudum Andrew	Chief Executive Officer	Jul 21 '25	Sale	49.54	125,335	6,208,637	92,313	Jul 23 04:12 PM
Chi Michael	Officer	Jul 23 '25	Proposed Sale	56.00	13,750	770,000		Jul 23 12:19 PM
Melissa Baird	Officer	Jul 21 '25	Proposed Sale	47.60	33,333	1,586,651		Jul 21 04:59 PM
Dudum Andrew	Officer	Jul 21 '25	Proposed Sale	49.54	125,335	6,208,636		Jul 21 10:41 AM
Dudum Andrew	Chief Executive Officer	Jul 16 '25	Sale	50.25	47,534	2,388,817	190,126	Jul 18 04:29 PM
Dudum Andrew	Chief Executive Officer	Jul 16 '25	Sale	50.58	2,792	141,217	92,313	Jul 18 04:29 PM
Dudum Andrew	Officer	Jul 16 '25	Proposed Sale	50.27	50,326	2,530,033		Jul 16 11:49 AM
Boughton Soleil	Chief Legal Officer	Jul 14 '25	Sale	47.82	2,572	122,993	158,165	Jul 15 04:28 PM
Okupe Oluyemi	Chief Financial Officer	Jul 14 '25	Option Exercise	5.01	7,587	38,011	65,665	Jul 15 04:28 PM
Okupe Oluyemi	Chief Financial Officer	Jul 14 '25	Sale	47.70	11,581	552,418	54,084	Jul 15 04:28 PM
Boughton Soleil	Officer	Jul 14 '25	Proposed Sale	47.82	2,572	122,993		Jul 14 12:25 PM
Melissa Baird	Officer	Jul 08 '25	Proposed Sale	48.96	33,333	1,631,984		Jul 08 04:48 PM
Okupe Oluyemi	Chief Financial Officer	Jul 07 '25	Option Exercise	5.01	6,437	32,249	69,659	Jul 08 04:40 PM
Okupe Oluyemi	Chief Financial Officer	Jul 07 '25	Sale	46.67	11,581	540,498	58,078	Jul 08 04:40 PM
Boughton Soleil	Chief Legal Officer	Jun 30 '25	Sale	50.50	2,572	129,886	160,737	Jul 01 04:45 PM
Boughton Soleil	Officer	Jun 30 '25	Proposed Sale	50.50	2,572	129,886		Jun 30 10:56 AM
Okupe Oluyemi	Chief Financial Officer	Jun 23 '25	Sale	47.25	23,107	1,091,766	63,222	Jun 24 04:31 PM
Oluyemi Okupe	Officer	Jun 23 '25	Proposed Sale	41.98	69,431	2,914,713		Jun 23 04:49 PM
Chi Michael	Chief Commercial Officer	Jun 17 '25	Sale	59.75	17,102	1,021,844	278,654	Jun 17 08:07 PM
Dudum Andrew	Chief Executive Officer	Jun 16 '25	Option Exercise	2.43	125,335	304,564	285,550	Jun 17 08:07 PM
Dudum Andrew	Chief Executive Officer	Jun 16 '25	Sale	56.76	128,127	7,271,950	160,215	Jun 17 08:07 PM
Dudum Andrew	Chief Executive Officer	Jun 17 '25	Sale	59.22	65,110	3,855,542	95,105	Jun 17 08:07 PM
Dudum Andrew	Chief Executive Officer	Jun 16 '25	Sale	56.51	47,534	2,686,300	237,660	Jun 17 08:07 PM
Boughton Soleil	Chief Legal Officer	Jun 16 '25	Sale	56.80	5,451	309,617	165,881	Jun 17 08:06 PM
Boughton Soleil	Chief Legal Officer	Jun 17 '25	Sale	59.75	2,572	153,677	163,309	Jun 17 08:06 PM
Becklund Irene	PAO	Jun 17 '25	Sale	59.75	8,485	506,979	712	Jun 17 08:06 PM
Chi Michael	Officer	Jun 17 '25	Proposed Sale	59.75	17,102	1,021,844		Jun 17 12:42 PM
Dudum Andrew	Officer	Jun 17 '25	Proposed Sale	59.22	65,110	3,855,544		Jun 17 12:13 PM
Becklund Irene	Officer	Jun 17 '25	Proposed Sale	59.75	8,485	506,979		Jun 17 11:19 AM
Boughton Soleil	Officer	Jun 17 '25	Proposed Sale	59.75	2,572	153,677		Jun 17 10:20 AM
Melissa Baird	Officer	Jun 16 '25	Proposed Sale	59.78	33,333	1,992,647		Jun 16 05:58 PM
Dudum Andrew	Officer	Jun 16 '25	Proposed Sale	56.49	47,534	2,685,348		Jun 16 02:42 PM
Boughton Soleil	Officer	Jun 16 '25	Proposed Sale	56.80	5,451	309,617		Jun 16 11:53 AM
Dudum Andrew	Officer	Jun 16 '25	Proposed Sale	56.43	128,127	7,230,643		Jun 16 11:24 AM
Chi Michael	Chief Commercial Officer	Jun 10 '25	Option Exercise	6.82	5,400	36,828	261,980	Jun 11 08:09 PM
Chi Michael	Chief Commercial Officer	Jun 10 '25	Sale	57.00	5,600	319,200	256,380	Jun 11 08:09 PM
Chi Michael	Officer	Jun 10 '25	Proposed Sale	57.00	5,400	307,800		Jun 10 12:12 PM
Chi Michael	Chief Commercial Officer	Jun 05 '25	Option Exercise	13.90	28,776	399,986	256,580	Jun 09 04:58 PM
Chi Michael	Chief Commercial Officer	Jun 06 '25	Option Exercise	13.20	5,100	67,335	260,180	Jun 09 04:58 PM
Chi Michael	Chief Commercial Officer	Jun 06 '25	Sale	56.00	5,100	285,600	256,580	Jun 09 04:58 PM
Chi Michael	Officer	Jun 06 '25	Proposed Sale	56.00	5,100	285,600		Jun 06 01:19 PM
Melissa Baird	Officer	Jun 04 '25	Proposed Sale	53.61	33,333	1,786,982		Jun 04 04:46 PM
Okupe Oluyemi	Chief Financial Officer	May 28 '25	Option Exercise	5.01	6,437	32,249	120,253	May 30 04:28 PM
Okupe Oluyemi	Chief Financial Officer	May 28 '25	Sale	52.98	11,581	613,537	39,153	May 30 04:28 PM
Boughton Soleil	Chief Legal Officer	May 27 '25	Sale	55.87	3,233	180,628	153,194	May 29 05:56 PM
Becklund Irene	PAO	May 22 '25	Sale	53.51	5,071	271,349	0	May 27 04:59 PM
Melissa Baird	Officer	May 27 '25	Proposed Sale	53.36	33,333	1,778,649		May 27 04:44 PM
Boughton Soleil	Officer	May 27 '25	Proposed Sale	55.87	3,233	180,628		May 27 11:12 AM
Becklund Irene	Officer	May 22 '25	Proposed Sale	53.51	5,071	271,349		May 22 09:45 AM
Okupe Oluyemi	Chief Financial Officer	May 15 '25	Option Exercise	10.97	6,437	70,646	125,397	May 19 06:35 PM
Okupe Oluyemi	Chief Financial Officer	May 15 '25	Sale	60.22	11,581	697,462	113,816	May 19 06:35 PM
Dudum Andrew	Chief Executive Officer	May 16 '25	Option Exercise	2.43	125,335	304,564	197,645	May 19 06:35 PM
Dudum Andrew	Chief Executive Officer	May 16 '25	Sale	58.40	128,127	7,482,414	89,311	May 19 06:35 PM
Dudum Andrew	Chief Executive Officer	May 16 '25	Sale	58.25	47,534	2,768,974	285,194	May 19 06:35 PM

open in yahoo | open in reuters | open in marketwatch | open in google | open in EDGAR

HIMS

Hims & Hers Health Inc

Upgrade your FINVIZ experience